Katsuhiro Masago - Concepedia

Author

Katsuhiro Masago

Foundation for Biomedical Research and Innovation ORCID

Also Known As

K. Masago, KATSUHIRO MASAGO, Kaito Masago, Katsuhiro Masago

167

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Foundation for Biomedical Research and Innovation Kyoto University Aichi Cancer Center Kyoto University Hospital Kobe City Medical Center General Hospital

About

Katsuhiro Masago is an author at Foundation for Biomedical Research and Innovation specializing in medicine, lung cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	32	1.4K
2	Health Sciences	4	4	102
3	Engineering	1	1	36
4	Natural Sciences	1	1	10
5	Public Health	1	1	36

Katsuhiro Masago

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer Yosuke Togashi, Katsuhiro Masago, Satohiro Masuda, Cancer Chemotherapy and Pharmacology Cerebrospinal Fluid ConcentrationMedicinePathologyBronchial NeoplasmCancer Treatment	2012	282
Spatiotemporal T790M Heterogeneity in Individual Patients with EGFR-Mutant Non–Small-Cell Lung Cancer after Acquired Resistance to EGFR-TKI Akito Hata, Nobuyuki Katakami, Hiroshige Yoshioka, Journal of Thoracic Oncology Tumor BiologyIndividual PatientsAcquired ResistanceTumor HeterogeneityMedicine	2015	156
Transformation to SCLC after Treatment with the ALK Inhibitor Alectinib Shiro Fujita, Katsuhiro Masago, Nobuyuki Katakami, Journal of Thoracic Oncology	2016	132
Cerebrospinal Fluid Concentration of Erlotinib and its Active Metabolite OSI-420 in Patients with Central Nervous System Metastases of Non-small Cell Lung Cancer Yosuke Togashi, Katsuhiro Masago, Masahide Fukudo, Journal of Thoracic Oncology Cerebrospinal Fluid ConcentrationMedicineMetronomic TherapyPharmacologyActive Metabolite Osi-420	2010	130
CT-Guided Fine-Needle Aspiration and Core Needle Biopsies of Pulmonary Lesions: A Single-Center Experience With 750 Biopsies in Japan Jumpei Takeshita, Katsuhiro Masago, Ryoji Kato, American Journal of Roentgenology	2014	113
Population Pharmacokinetics/Pharmacodynamics of Erlotinib and Pharmacogenomic Analysis of Plasma and Cerebrospinal Fluid Drug Concentrations in Japanese Patients with Non-Small Cell Lung Cancer Masahide Fukudo, Yasuaki Ikemi, Yosuke Togashi, Clinical Pharmacokinetics Pharmacogenomic AnalysisMedicinePopulation Pharmacokinetics/pharmacodynamicsPharmacologyBronchial Neoplasm	2013	86
Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation Yosuke Togashi, Katsuhiro Masago, Masahide Fukudo, Cancer Chemotherapy and Pharmacology Cancer ManagementPathologyPharmacotherapyNeuro-oncologyOncology	2011	75
ROS1 Immunohistochemistry Among Major Genotypes of Non–Small-Cell Lung Cancer Theresa A. Boyle, Katsuhiro Masago, Kim E. Ellison, Clinical Lung Cancer	2014	64
Association of diffuse, random pulmonary metastases, including miliary metastases, with epidermal growth factor receptor mutations in lung adenocarcinoma Yosuke Togashi, Katsuhiro Masago, Takeshi Kubo, Cancer	2010	64
Epidermal growth factor receptor gene mutations in papillary thyroid carcinoma Katsuhiro Masago, Ryo Asato, Shiro Fujita, International Journal of Cancer PathologyHigh FrequencyTumor BiologyOncologyPapillary Thyroid Carcinoma	2008	55

Page 1